Eagle Pharmaceuticals, Inc. to Present at Investor Conferences in June

Wednesday, May 31, 2017 4:30 pm EDT

Dateline:

WOODCLIFF LAKE, N.J.

Public Company Information:

NASDAQ:
EGRX

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) announced today that management will present at two investor conferences in June as follows:

             

Conference:

Jefferies 2017 Global Healthcare Conference

Date: Thursday, June 8, 2017
Time: 1:30 p.m. Eastern Daylight Time
Location: Grand Hyatt New York, NYC

Presenters:

Scott Tarriff, Chief Executive Officer, and David Pernock, President and Chief Commercial Officer

Webcast:

http://wsw.com/webcast/jeff105/egrx

             

Conference:

William Blair 37th Annual Growth Stock Conference

Date: Wednesday, June 14, 2017
Time: 1:20 p.m. Central Daylight Time
Location: Four Seasons Hotel, Chicago

Presenters:

David Pernock, President and Chief Commercial Officer, and David Riggs, Executive Vice President of Administration

Webcast:

http://wsw.com/webcast/blair53/egrx

 

The presentations will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the company’s website at www.eagleus.com, under the Investors Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the company’s website at www.eagleus.com.

Contact:

Investor Relations for Eagle Pharmaceuticals, Inc:
Lisa M. Wilson, 212-452-2793
lwilson@insitecony.com